Header cover image

U.K. (FTSE) Healthcare Sector Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies115
  • 7D-1.6%
  • 3M-2.1%
  • 1Y8.8%
  • YTD9.8%

Over the last 7 days, the Healthcare industry has dropped 1.6%, driven by a decline by AstraZeneca of 0.8%. Meanwhile, HUTCHMED (China) actually outperformed within the industry, gaining 18% in the last week. This takes the industry's 12 month performance to a gain of 8.8%.

Sector Valuation and Performance

Has the U.K. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021UK£273.6bUK£75.8bUK£6.1b30.3x
Tue, 26 Oct 2021UK£280.2bUK£71.9bUK£7.8b30.1x
Thu, 23 Sep 2021UK£272.5bUK£71.8bUK£7.9b31.8x
Sat, 21 Aug 2021UK£279.1bUK£71.4bUK£7.9b32.8x
Sat, 05 Jun 2021UK£237.4bUK£69.0bUK£8.7b36.6x
Tue, 09 Mar 2021UK£208.3bUK£69.7bUK£8.2b44.7x
Mon, 30 Nov 2020UK£224.7bUK£70.4bUK£8.3b44.1x
Thu, 03 Sep 2020UK£234.8bUK£72.2bUK£8.6b41.3x
Sun, 07 Jun 2020UK£246.9bUK£72.1bUK£7.1b34.3x
Sat, 29 Feb 2020UK£215.0bUK£68.4bUK£6.7b34.8x
Tue, 03 Dec 2019UK£233.7bUK£69.3bUK£7.5b29.2x
Fri, 06 Sep 2019UK£145.4bUK£34.2bUK£2.8b31.8x
Mon, 10 Jun 2019UK£197.9bUK£64.1bUK£6.6b34.3x
Sun, 03 Mar 2019UK£193.2bUK£63.7bUK£5.9b30.4x
Wed, 05 Dec 2018UK£200.0bUK£61.9bUK£3.6b30.8x
PE Ratio

30.8x

Total Market Cap: UK£200.0bTotal Earnings: UK£3.6bTotal Revenue: UK£61.9b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 34.9x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 19% per year over the last three years, and revenues for these companies have grown 7.0% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare sector?

Pharma-0.71%
Healthtech-1.96%
Biotech-4.80%
Medical Equipment-5.82%
Healthcare Services-6.61%
Life Sciences-7.34%

Industry PE: Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 43.9x. This is likely because analysts are expecting annual earnings growth of 20%, which is higher than its past year's earnings growth of 8.5% per year. Meanwhile, investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 29.1x.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 25% over the next 5 years. This is better than its past earnings decline of 21% per year. Meanwhile, the Life Sciences industry is expected to see its earnings grow by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
HCM HUTCHMED (China)17.7%+UK£685.1m16.2%PS21.8x
SAR Sareum Holdings29.7%+UK£45.5m314.0%PB72x
SNG Synairgen4.2%+UK£14.7m115.3%PB7x
MHC MyHealthChecked40.5%+UK£6.3m88.2%PS6.6x
GDR genedrive25.4%+UK£4.3m-59.3%PS31x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GNS

UK£49.30

Genus

7D

-10.1%

1Y

18.9%

GDR

UK£0.23

genedrive

7D

25.4%

1Y

-59.3%